ZA98611B - Imino-aza-anthracyclinone derivatives - Google Patents

Imino-aza-anthracyclinone derivatives

Info

Publication number
ZA98611B
ZA98611B ZA98611A ZA98611A ZA98611B ZA 98611 B ZA98611 B ZA 98611B ZA 98611 A ZA98611 A ZA 98611A ZA 98611 A ZA98611 A ZA 98611A ZA 98611 B ZA98611 B ZA 98611B
Authority
ZA
South Africa
Prior art keywords
aza
imino
anthracyclinone derivatives
anthracyclinone
derivatives
Prior art date
Application number
ZA98611A
Other languages
English (en)
Inventor
Michele Caruso
Daniela Faiardi
Tiziano Bandeira
Jacqueline Lansen
Antonino Suarato
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of ZA98611B publication Critical patent/ZA98611B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
ZA98611A 1997-01-27 1998-01-26 Imino-aza-anthracyclinone derivatives ZA98611B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701628.1A GB9701628D0 (en) 1997-01-27 1997-01-27 Imino-aza-anthracyclinone derivatives

Publications (1)

Publication Number Publication Date
ZA98611B true ZA98611B (en) 1998-08-17

Family

ID=10806639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98611A ZA98611B (en) 1997-01-27 1998-01-26 Imino-aza-anthracyclinone derivatives

Country Status (25)

Country Link
US (1) US6194422B1 (xx)
EP (1) EP0970080B1 (xx)
JP (1) JP2001511123A (xx)
KR (1) KR20000070483A (xx)
CN (1) CN1103774C (xx)
AR (1) AR011572A1 (xx)
AT (1) ATE235494T1 (xx)
AU (1) AU745981B2 (xx)
BR (1) BR9815448A (xx)
CA (1) CA2277951C (xx)
DE (1) DE69812599T2 (xx)
DK (1) DK0970080T3 (xx)
EA (1) EA001887B1 (xx)
ES (1) ES2195313T3 (xx)
GB (1) GB9701628D0 (xx)
HU (1) HUP0001222A3 (xx)
IL (1) IL130831A (xx)
NO (1) NO313198B1 (xx)
NZ (1) NZ337221A (xx)
PL (1) PL190304B1 (xx)
PT (1) PT970080E (xx)
TW (1) TW519544B (xx)
UA (1) UA57063C2 (xx)
WO (1) WO1998032754A1 (xx)
ZA (1) ZA98611B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902938D0 (en) * 1999-02-10 1999-03-31 Novartis Ag Organic compounds
GB9911804D0 (en) * 1999-05-20 1999-07-21 Merck Sharp & Dohme Therapeutic combination
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9376406B2 (en) 2011-03-03 2016-06-28 Indiana University Research And Technology Corporation uPAR-uPA interaction inhibitors and methods for treating cancer
US8846882B2 (en) 2011-04-29 2014-09-30 Synbias Pharma Ag Method of producing 4-demethoxydaunorubicin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
GB9416007D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives
GB9516349D0 (en) * 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives

Also Published As

Publication number Publication date
KR20000070483A (ko) 2000-11-25
EP0970080A1 (en) 2000-01-12
HUP0001222A3 (en) 2001-01-29
US6194422B1 (en) 2001-02-27
DK0970080T3 (da) 2003-07-21
CA2277951A1 (en) 1998-07-30
NO313198B1 (no) 2002-08-26
NZ337221A (en) 2001-01-26
CA2277951C (en) 2006-06-06
BR9815448A (pt) 2001-10-16
GB9701628D0 (en) 1997-03-19
ES2195313T3 (es) 2003-12-01
PL334803A1 (en) 2000-03-13
CN1244866A (zh) 2000-02-16
AU5863398A (en) 1998-08-18
CN1103774C (zh) 2003-03-26
IL130831A (en) 2005-08-31
TW519544B (en) 2003-02-01
IL130831A0 (en) 2001-01-28
PT970080E (pt) 2003-07-31
PL190304B1 (pl) 2005-11-30
AR011572A1 (es) 2000-08-30
ATE235494T1 (de) 2003-04-15
WO1998032754A1 (en) 1998-07-30
NO993549L (no) 1999-09-21
NO993549D0 (no) 1999-07-20
EP0970080B1 (en) 2003-03-26
HUP0001222A2 (hu) 2000-10-28
EA001887B1 (ru) 2001-10-22
UA57063C2 (uk) 2003-06-16
EA199900684A1 (ru) 2000-04-24
DE69812599T2 (de) 2004-01-08
AU745981B2 (en) 2002-04-11
JP2001511123A (ja) 2001-08-07
DE69812599D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HRP970174B1 (en) 6-phenylpyridil-2-amine derivatives
AP9701156A0 (en) 6-phenylpyridyl-2-amine derivatives
IL125379A (en) 19-nor-pregnene derivatives
HUP9801168A3 (en) Triazinylaminostilbene derivatives
HUP9902993A3 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
HUP9701835A3 (en) Vinyl-pirrolidinone-cephalosporin derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
IL125149A0 (en) Pyrazol-4-yl-hetaroyl derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
PL340541A1 (en) Pyridipyrrole derivative
GB2321457B (en) 5-Aroylnaphthalene derivatives
HU9701479D0 (en) N-benzylazolium derivatives
GB9604996D0 (en) Benzodiazonine derivatives
ZA98611B (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9603226D0 (en) Heterocyclyl-ergoline derivatives
GB9600063D0 (en) Guaridine derivatives
ZA983116B (en) Arylsecocholadiene derivatives
ZA983168B (en) New naphthylpiperazine derivatives
GB9702049D0 (en) Tetrahhydroisoquinoline derivatives